Enliven Therapeutics ELVN
NASDAQ ELVN
$41.52 -0.41 (-0.98%)
At close: Oct 23, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Price to Sales (2020 - 2026)

Updated

Analysis

Enliven Therapeutics (ELVN) Price to Sales (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Enliven Therapeutics 2.74 Bn 452.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 201.01
Mar 31, 2026 140.30
Dec 31, 2025 57.16
Sep 30, 2025 80.28
Jun 30, 2025 84.85
Mar 31, 2025 65.05
Dec 31, 2024 73.94
Sep 30, 2024 82.99
Jun 30, 2024 77.66
Mar 31, 2024 60.85
Dec 31, 2023 47.75
Sep 30, 2023 61.10
Jun 30, 2023 137.69
Mar 31, 2023 144.09
Dec 31, 2022 95.23
Sep 30, 2022 101.93
Jun 30, 2022 134.75
Mar 31, 2022 310.82
Dec 31, 2021 209.18
Sep 30, 2021 388.42
API Access

Enliven Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ELVN&period=max&api_key=YOUR_API_KEY